Bellerophon Therapeutics Company
Bellerophon focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary diseases.
Investors
Founded Date:
2009
Investor Type:
N/A
Employee Number:
11-50
Investment Stage:
N/A
Funding Status:
IPO
Number Of Exists:
N/A
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Warren, New Jersey, United States
Estimated Revenue:
$1M to $10M